Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 20, 2023
“Why doesn’t cancer metastasize to your muscles?”
From the Ghajar Lab, Breast & Ovary Cancer Program, Cancer Consortium
Fred Hutch Evergreen Fund awards six grants to promising projects
Scientists receive up to $200K to boost research for projects deemed to have partnership potential
Cancer cells reconnect with their inner child to evade immunotherapy
Turning on an embryonic gene may help some tumors resist immune checkpoint inhibitors
New Research Identifies Gene That Hides Cancer Cells from Immunotherapy
Findings in Developmental Cell show that expression of an early developmental gene prevents the immune system from identifying and attacking cancer cells
Study uncovers new proteins involved in regulating muscular dystrophy-linked gene
CRISPR-based proteomics technique reveals potential therapeutic targets for FSHD, a rare but devastating disease
Good News: Dr. Cyrus Ghajar receives $1M from Keck Foundation to study why cancer doesn’t spread to skeletal muscle
Celebrating faculty and staff achievements
Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care
Celebrating faculty and staff achievements
Remembering Fred Hutch's Dr. Harold Weintraub 20 years later
20 years after Dr. Harold Weintraub’s death, his life — and his research — are still making a difference
Muscle or neuron? A simple swap can redirect cell fate
Alter just one section of the protein responsible for making a muscle cell a muscle cell — and it makes nerve cells instead
Glaxosmithkline partnership will target muscular dystrophy
Agreement merges Dr. Stephen Tapscott’s breakthrough research on facioscapulohumeral muscular dystrophy with drug-discovery expertise
Fred Hutch GSK Partnership - Fred Hutchinson Cancer Research Center
Collaboration represents first U.S. institution chosen to participate in GSK academic-industry partnership
Tapscott team finds two genetic flaws fuel form of muscular dystrophy
Latest in a series of breakthrough discoveries by the Fred Hutchinson Cancer Research Center’s Stephen Tapscott and an international team of researchers may lead to biomarker tests, new treatments
Four Fred Hutchinson Cancer Research Center teams win Hartwell Innovation Fund awards
Each team of scientists will receive $80,000 grants to jump-start innovative and high-risk, high-reward research opportunities
Tapscott Lab's Geng among Weintraub winners
Molecular and cell biologist Linda Geng is one of 13 recipients nationwide of the Center's 2012 Harold M. Weintraub Graduate Student Award
Tapscott team discovers genes, mechanisms of common muscular dystrophy
Discoveries may result in biomarker test for facioscapulohumeral muscular dystrophy, a disease that initially affects the skeletal muscles of the face, scapula and upper arms
International research team discovers genes and disease mechanisms behind a common form of muscular dystrophy
Discovery could lead to a biomarker-based test for diagnosis
Center hosts 15th Weintraub reunion meeting Nov. 4, 5
Former graduate students, postdoctoral fellows and collaborators of the late Dr. Harold Weintraub will gather to discuss their work and celebrate Weintraub’s scientific legacy
‘Dead gene’ plays key role in muscular dystrophy
Tapscott’s global team discovers expression of an MD-causing gene thought to be inactive in humans; work may lead to new therapy targets, evolutionary insights